"Intensive chemotherapy" refers to a strong and powerful treatment for cancer. It involves the use of high doses of strong medications to kill cancer cells and stop the progression of the disease. The treatment is often given in cycles, with periods of rest in between. It is called "intensive" because it is more aggressive than regular chemotherapy, with the goal of providing the best chance of curing or controlling the cancer.
Full definition
The doctors» plan was to kill off Brown's cancer - producing bone marrow cells
with intensive chemotherapy and replace them with stem cells from the bone marrow of a healthy donor.
After two years
of intensive chemotherapy for late - stage colon cancer, and having outlived her prognosis by several months, shed finally lost hope.
From developing the first pediatric protective environment in 1971 for children
undergoing intensive chemotherapy, to pioneering current efforts to develop academic and clinical care programs nationally and locally for adolescents and young adults with cancer, Dr. Siegel's contributions have revolutionized the field of pediatric oncology.
If the technique proves successful, it might also be possible to treat kidney tumours outside the body
using intensive chemotherapy, while the patient survives on a dialysis machine.
Clinicians have historically been hesitant to treat HIV patients with stem cell transplant due to concerns that their immune systems would not effectively recover
after intensive chemotherapy or that the procedure would cause excessive toxicities or infections post-transplant.
A patient
receives intensive chemotherapy with or without total body irradiation therapy in an attempt to kill all cancerous cells, but which also destroy his / her own bone marrow function.
The 54 - year - old neuropsychologist underwent her psilocybin session at UCLA last May, shortly after her ovarian cancer had come roaring back in spite of two rounds
of intensive chemotherapy.
Dr. Rassool says that a clinical trial is planned to test whether low doses of a DNMT inhibitor, decitabine, and an investigational PARP inhibitor, talazoparib, can be safely combined and whether this therapy shows efficacy for AML patients, especially those who can not receive
intensive chemotherapy, whose leukemia is resistant to treatment, or who have experienced a relapse after treatment.
The disease mainly affects babies and young children, and while in some cases the tumours can disappear of their own accord, the majority are aggressive, metastasising cancer tumours that are resistant to modern combinations of surgery, radiotherapy and
intensive chemotherapy.
Less than 50 % of dogs treated with standard - of - care of care for this tumor (surgery and
intensive chemotherapy) survive more than six months.